StockCIK 1156039

Elevance Health, Inc. (ELV): Insider Trades and Fund Holdings

In the past 12 months, Elevance Health, Inc. insiders reported 0 open-market purchases worth $0 and 1 sale worth $4.66M; 0 of the sales were reported as made under a 10b5-1 trading plan.

0Insider buys, 12 months

$0Bought by insiders, 12 months

$4.66MSold by insiders, 12 months

3Tracked funds holding

Recent insider trades

Open-market purchases (code P) and sales (code S) from Form 4. Grants, option exercises and gifts are not shown. Latest filing: Oct 23, 2026.

Recent ELV insider trades
Filed	Traded	Insider	Role	Type	Shares	Price ($)	Value	Holding	Filing
Oct 23	Oct 22	Mark KayeCFO	CFO	▼ SELL	10,584	440.13	$4.66M	−33%	Form 4 ↗

Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings

Insiders who traded in the past year

Insider	Role	Buys	Bought	Sells	Sold	Latest
Mark Kaye	CFO	0	$0	1	$4.66M	Oct 23, 2026

Tracked funds that report ELV

From each fund's latest 13F. Holdings are as of quarter end and are filed up to 45 days later.

Fund	Quarter	Shares	Value	% of portfolio	Change
Ruane, Cunniff & Goldfarb	Q2 2026	979,598	$378.8M	5.89%	▼ −29.4%
Renaissance Technologies	Q2 2026	201,373	$77.9M	0.11%	▲ +1193.1%
Baupost Group	Q2 2026	1,275,154	$493K	9.11%	No change

Source: SEC Form 13F-HR filings, retrieved Oct 28, 2026. How we read filings

Reading these numbers

Insiders sell for many reasons: taxes, diversification, a house. Purchases with their own money are rarer and are usually read as more informative. A Form 4 is due within two business days of the trade. How to read a Form 4 →